RxSchool - Pharmacy Continuing Education
Home | Catalog | About Us | Search Pharmacy Jobs | Help  
New User? Register Here    

 (ProCE) Type-2 Diabetes: Managing the Complexity of Current and Emerging Treatments
  Course Information Back to Catalog   

This lesson is supported by:

This program was developed by ProCE, Inc. and supported
by an educational grant from Takeda Pharmaceuticals North America, Inc.


Type-2 Diabetes: Managing the Complexity of Current and Emerging Treatments

Program Description:
Nearly 20 million people in the United States are living with type 2 diabetes (T2DM) and are at elevated risk of morbidity and mortality.  Despite efforts in public and professional education, the incidence of T2DM continues to rise at an alarming rate.  New drugs indicated for T2DM continue to be introduced to the market and new study results are being presented at a rapid pace.  However, clinicians are challenged to keep current with new therapies, the various study results, and where these treamtents fit into an increasingly complicated treatment scheme for T2DM patients.

The ability of the clinician to manage T2DM patients is dependent on an in-depth understanding of currently available therapies (alone and in combination), side effects, drug interactions and monitoring parameters.  Additionally, many T2DM patients have or are at risk of co-morbid conditions, such as CVD.  Therefore, the clinician must also maintain an in-depth understanding of the impact of T2DM therapies on co-morbid conditions and how these therapies may interact with the patient's other drug regimens.

Learning Objectives

At the completion of this program, the participant will be able to:

  1. List current and emerging treatment options for  type-2 diabetes and integrate recent study results in patient management
  2. Outline combination therapy strategies for type-2 diabetes and monitoring parameters necessary to reach therapy goals
  3. Evaluate the potential impact of type-2 diabetes therapies on cardiovascular disease and treatment regimens
  4. Correlate specific patient variables with appropriate drug regimens to maximize patient outcomes
David W. Bartels, PharmD, BCPS, CDE, FCCP
Director, Pharmacy Education Programs
Clinical Associate Professor
University of Illinois at Chicago College of Pharmacy and University of Illinois at Rockford College of Medicine
Chicago & Rockford, Illinois

Mark Stolar, MD
Associate Professor, Clinical Medicine
Northwestern University Medical School
Chicago, Illinois

Curtis Triplitt, PharmD, CDE
Texas Diabetes Institute
Assistant Professor of Medicine
Division of Diabetes
University of Texas Health Science Center at San Antonio
San Antonio, Texas

Target Audience:
The target audience for this program is pharmacists in health-system settings.

Faculty Disclosure:
It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation.  Dr. Bartels reports receiving grant support from Sanofi-Aventis and Eli Lilly, and serving as a speaker or consultant for Sanofi-Aventis, Pfizer and Takeda.  Dr. Stolar reports serving as a speaker form Amylin, Eli Lilly and Takeda.  Dr. Triplitt reports serving as a speaker or consultant for Amylin, Novartis, Pfizer and Takeda.

Please note: The opinions expressed in this program should not be construed as those of the CME/CE provider.  The information and views are those of the faculty through clinical practice and knowledge of the professional literature.  Portions of this program may include the use of drugs for unlabeled indications.  Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

Course Category This activity has been designated as Knowledge-Based
Technologies Used

Macromedia Flash Macromedia Flash

Price: FREE!
ACPE - Pharmacists Accreditation
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This home study web activity has been assigned a maximum of 2 credit hours and the ACPE UAN: 221-000-08-008-H01-P.

Expiration Date: 02/09/2011

To receive educational credit, participants must pass the online assessment with a score of 70% or better. If you do not receive a minimum score of 70% or better, you are permitted to retake the test. After passing the assessment, you can view, print and track your statements of credit online. There is no fee to participate in this activity.

The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

This lesson is supported by:

Home | About Us | Courses | Continuing Education | Help | Contact Us

Copyright � 2000 - 2019 RxSchool - All rights reserved.

Nursing CE

Privacy Statement | Policies and Procedures | Terms and Conditions of Service